Company Filing History:
Years Active: 2021
Title: Innovations in Neurological Research by David R Boyer
Introduction
David R Boyer is an accomplished inventor based in Santa Monica, CA. He has made significant contributions to the field of neurological research, particularly in understanding the aggregation of Tau protein, which is linked to various neurological disorders, including Alzheimer's disease. His work focuses on developing innovative solutions to inhibit Tau aggregation, which is crucial for advancing treatment options for these conditions.
Latest Patents
David R Boyer holds a patent for "Structure-based peptide inhibitors that target the Tau VQIINK fibrillization segment." This patent addresses the aggregation of Tau protein, which is associated with over 20 neurological disorders. His research indicates that the VQIINK segment is a more powerful driver of Tau aggregation compared to other segments. The findings from his work have led to the design of effective peptide inhibitors that can significantly inhibit Tau aggregation and its ability to seed intracellular Tau in mammalian cells.
Career Highlights
Boyer's career is marked by his dedication to understanding the molecular mechanisms behind Tau protein aggregation. His innovative approach combines structural biology with peptide design, leading to breakthroughs in the development of therapeutic agents. His work has the potential to impact the treatment of Alzheimer's disease and other related disorders.
Collaborations
David R Boyer has collaborated with notable researchers in the field, including David S Eisenberg and Paul M Seidler. These collaborations have enriched his research and contributed to the advancement of knowledge in neurological disorders.
Conclusion
David R Boyer's contributions to the field of neurological research through his innovative patent and collaborative efforts highlight the importance of understanding protein aggregation in developing effective treatments for Alzheimer's disease and other neurological disorders. His work continues to pave the way for future advancements in this critical area of research.